Assessing long-term prognosis improvement as a consequence of treatment pattern changes in MS

Abstract

Objective:

To assess whether the age at which multiple sclerosis (MS) patients reach Expanded Disability Status Scale (EDSS) milestones changed as long as new drugs for the treatment of MS became available.

Methods:

We evaluated the long-term impact of therapies on disability progression assessing whether there is a detectable delay in the age at which patients reached EDSS milestones in more recent years. We used data collected over more than 30 years in the Center of Brescia, Italy. We compared the age at EDSS = 6 among patients diagnosed with relapsing-remitting MS in different time periods, adjusting for age at diagnosis and median interval among EDSS visits, by a multivariate Cox model.

Results:

A total of 1324 MS patients were included. Patients diagnosed in more recent periods reached EDSS = 6 at an older age: the rate at which patients reached EDSS = 6 in those diagnosed in 1991–1995 was similar to those diagnosed in 1980–1990 (hazard ratio (HR) = 1.09, p = 0.68) and to those diagnosed in 1996–2000 (HR = 0.85, p = 0.44), it was reduced by 37% in patients diagnosed in 2001–2005 (HR = 0.63, p = 0.05), by 46% in patients diagnosed in 2006–2010 (HR = 0.54, p < 0.02).

Conclusion:

A clear modification of MS course is observed after 2000; among other causes, this can be associated to the changes in the treatment patterns experienced in those years.

Keywords

Multiple sclerosis long-term treatment effect real life

Get full access to this article

View all access options for this article.

References

Confavreux

Vukusic

Adeleine

. Early clinical predictors and progression of irreversible disability in multiple sclerosis: An amnesic process. Brain 2003; 126: 770–782.

Sormani

Bruzzi

. Can we measure long-term treatment effects in multiple sclerosis? Nat Rev Neurol 2015; 11: 176–182.

Poser

Paty

Scheinberg

et al . New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227–231.

McDonald

Compston

Edan

et al . Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121–127.

Polman

Reingold

Edan

et al . Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.” Ann Neurol 2005; 58: 840–846.

Sormani

Tintorè

Rovaris

et al . Will Rogers phenomenon in multiple sclerosis. Ann Neurol 2008; 64: 428–433.

Inusah

Sormani

Cofield

et al . Assessing changes in relapse rates in multiple sclerosis. Mult Scler 2010; 16: 1414–1421.

Kister

Chamot

Cutter

et al .; MSBase Investigators. Increasing age at disability milestones among MS patients in the MSBase Registry. J Neurol Sci 2012; 318: 94–99.

Veugelers

Fisk

Brown

et al . Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: A longitudinal population-based evaluation. Mult Scler 2009; 15: 1286–1294.